1.29
Stereotaxis Inc stock is traded at $1.29, with a volume of 1.30M.
It is down -8.51% in the last 24 hours and down -20.86% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$1.41
Open:
$1.41
24h Volume:
1.30M
Relative Volume:
1.96
Market Cap:
$128.52M
Revenue:
$31.20M
Net Income/Loss:
$-21.68M
P/E Ratio:
-5.2826
EPS:
-0.2442
Net Cash Flow:
$-15.52M
1W Performance:
-16.77%
1M Performance:
-20.86%
6M Performance:
-51.69%
1Y Performance:
-42.41%
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
STXS
Stereotaxis Inc
|
1.29 | 128.52M | 31.20M | -21.68M | -15.52M | -0.2442 |
|
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
Stereotaxis, Inc. (STXS) stock price, news, quote and history - Yahoo Finance UK
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026 - The Manila Times
Stereotaxis to Discuss Robotic Intervention Results on Aug. 11 - Stock Titan
Stereotaxis, Inc. opens new robotic EP laboratory in Hungary - Traders Union
University of Szeged Pioneers First Robotic Cardiology Program in Hungary - GlobeNewswire
University of Szeged Treats First Patients With Genesis System - Stock Titan
Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings - Yahoo Finance
STXS Slides As Stereotaxis Clears Massive Secondary Share Block - timothysykes.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Stereotaxis Faces Integration, Financial, and Regulatory Challenges Following Robocath Acquisition - Minichart
Stereotaxis completes acquisition of Robocath; issues 6.27M shares, up to $25M earnout possible - TradingView
Stereotaxis (NYSE American: STXS) flags Robocath earnouts and 19.9% dilution - Stock Titan
Stereotaxis Files Resale Registration for Up to 108.9 Million Shares - Moomoo
Form S-3 Stereotaxis Inc For: 15 July By Investing.com - Investing.com Nigeria
Stereotaxis Finalizes Robocath Acquisition - dicardiology.com
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? - TradingView
Stereotaxis closes Robocath takeover - MedTech Dive
Stereotaxis completes acquisition of Robocath By Investing.com - Investing.com India
Stereotaxis, Inc. completes Robocath acquisition to accelerate endovascular robotics expansion - Traders Union
Stereotaxis Closes $45M Deal for Robocath - Medical Product Outsourcing
Stereotaxis completes acquisition of Robocath - Investing.com
Robocath deal adds stock, warrants and earnouts at Stereotaxis (STXS) - Stock Titan
Stereotaxis Completes Acquisition of Robocath - GlobeNewswire
Stereotaxis folds Robocath into its surgical robotics platform - Stock Titan
Enterprise value to revenue forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Price to sales forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Enterprise value to EBITDA forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Stereotaxis, Inc. completed the acquisition of Robocath SAS. - marketscreener.com
Enterprise value to EBITDA forward of Stereotaxis, Inc. – LS:A1J09L - TradingView
Price to book forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Director Ross B. Levin receives 43,103 Stereotaxis (STXS) restricted share units - Stock Titan
Director at Stereotaxis (STXS) receives 43,103-share equity grant - Stock Titan
Stereotaxis (STXS) director awarded 43,103 restricted share units, holding 1,035,560 shares - Stock Titan
Robotics redefine electrophysiology, Stereotaxis, Inc. explores in latest podcast - Traders Union
STXS Q1 2026 Earnings: EPS Misses Estimates as Stock SlipsWeak Earnings Momentum - dars.gov.et
Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS) - Yahoo Finance
Stereotaxis Inc. (STXS) Holds Near Support Amidst Low VolatilityMomentum Stock Picks - dars.gov.et
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2000 Value Benchmark - marketscreener.com
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Price to earnings forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 3000 Value Benchmark - marketscreener.com
STXSStereotaxis Inc Options - Finviz
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2500 Value Benchmark - marketscreener.com
Stereotaxis, Inc. Hits New 52-Week Low at $1.60 Amid Decline - MarketsMojo
Stereotaxis (STXS) Gains 3.7% as Stock Hovers Near Key ResistanceSymmetrical Triangle - dars.gov.et
8 Most Promising Robotics Stocks Now - Insider Monkey
Enterprise value to EBIT forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Enterprise value to revenue forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView
Price to sales forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView
Stereotaxis, Inc. Actuals & Estimates (AMEX:STXS) - TradingView
STXS Q1 2026 Earnings: EPS Misses Estimates as Company Navigates Strategic TransitionQuarterly Financial Update - dars.gov.et
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):